查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573117

犬關節炎市場：按產品類型、給藥途徑、最終用戶、治療類型 - 全球預測 2025-2030

Canine Arthritis Market by Product Type (Assistive Devices and Joint Support, Disease-Modifying Osteoarthritis Drugs, Non-Steroidal Anti-Inflammatory Drugs ), Route of Administration, End User, Therapy Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

犬關節炎市場2023年估值為18.1億美元，預計到2024年將達到19.2億美元，複合年成長率為7.88%，到2030年預計將達到30.8億美元。

犬關節炎是一種退化性關節疾病，主要影響狗的軟骨，導致疼痛、僵硬和運動受損。由於寵物飼養量的增加和老年狗數量的增加等因素，犬關節炎的盛行率不斷增加，犬關節炎的治療和管理市場正在顯著擴大。不可否認，狗對有效關節炎治療的需求是不可否認的，這主要是由於人們對寵物福利的了解有所提高，以及寵物醫療保健人性化的趨勢不斷成長。關節炎管理的應用範圍從藥物干預（如非類固醇消炎劑(NSAID) 和緩解疾病骨關節炎藥物 (DMOAD)）到非藥物干預（如物理治療、針灸和營養食品）。最終用途包括獸醫診所、寵物醫院，甚至是希望維持寵物生活品質的飼主提供的居家照護解決方案。關鍵的成長要素包括獸醫學的進步，提供更新、更有效的治療方法，以及飼主對關節炎症狀和治療方法的認知提高。同時，在創新、微創治療技術的開發以及符合消費者對寵物有機和天然健康解決方案的偏好的自然或整體治療方案的擴散方面存在著開拓的機會。然而，市場成長受到一些挑戰的限制，例如與先進治療相關的高成本、缺乏寵物保險以及新興市場缺乏意識等。需要創新的領域包括用於早期檢測的增強診斷工具和基於個體基因圖譜的個人化治療計劃。市場動態的特徵是獸藥的快速發展和消費者資訊收集的活性化，這意味著公司不僅關注其治療的有效性，而且還關注擴大消費者教育和可及性，我們需要關注並推動成長。

主要市場統計
基準年[2023] 18.1億美元
預測年份 [2024] 19.2億美元
預測年份 [2030] 30.8億美元
複合年成長率（%） 7.88%

市場動態：揭示快速發展的犬關節炎市場的關鍵市場洞察

供需的動態交互作用正在改變犬類關節炎市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於寵物的老化和生活方式，世界狗群中關節炎的盛行率不斷增加
    • 獸醫醫學和治療方面的創新可有效控制狗的關節炎
    • 提高飼主對狗的健康和保健的認知和支出意願
    • 診斷技術的進步導致狗關節炎的早期發現和治療
  • 市場限制因素
    • 專業獸醫數量不足，無法妥善處理犬類關節炎病例
    • 影響犬關節炎新治療方法的核准和可用性的監管挑戰
  • 市場機會
    • 犬關節炎專科治療中心提供全面全面的醫療方法
    • 為患有關節炎的狗訂購關節補充品和止痛藥
    • 用於持續監測和管理狗的關節炎症狀的穿戴式技術
  • 市場挑戰
    • 獸醫護理和關節炎治療的高昂成本減少了市場進入。
    • 缺乏飼主對狗關節炎早期症狀和預防保健的認知和教育

波特的五力：駕馭犬關節炎市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解犬關節炎市場的外部影響

外部宏觀環境因素在塑造犬關節炎市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解狗狗關節炎市場的競爭格局

犬關節炎市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣犬關節炎市場供應商的績效評估

FPNV 定位矩陣是評估犬關節炎市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了犬關節炎市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對犬關節炎市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 寵物的老化和生活方式的改變正在增加世界各地狗狗關節炎的盛行率
      • 獸醫藥物和治療方法的創新可有效控制狗的關節炎
      • 提高狗狗的健康意識和飼主花錢的意願
      • 診斷技術的進步導致狗關節炎的早期發現和治療
    • 抑制因素
      • 沒有足夠的專業獸醫專業人員來充分處理狗的關節炎病例。
      • 影響犬關節炎新治療方法的核准和可用性的監管挑戰
    • 機會
      • 專業犬類關節炎治療中心提供全面且整體的醫療方法
      • 為患有關節炎的狗定期提供關節補充品和止痛藥
      • 穿戴式科技持續監測和管理狗狗的關節炎症狀
    • 任務
      • 獸醫和關節炎治療的高昂成本限制了市場進入
      • 寵物飼主對狗關節炎的早期徵兆和預防保健缺乏認知和教育。
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章犬關節炎市場：依產品類型

  • 輔助器具和關節支持
    • 大括號
    • 線束
    • 其他輔助器具
  • 骨關節炎治療藥（DMOAD）
    • 結構修飾DMOAD
    • 症狀性DMOAD
  • 非類固醇消炎劑(NSAID)
    • 市售非類固醇抗發炎藥
    • 處方非類固醇抗發炎藥
  • 疼痛管理藥物
    • 鴉片類藥物
    • 其他止痛藥
    • 類固醇
  • 手術治療
    • 關節鏡手術
    • 關節重建手術
    • 其他手術治療

第7章犬關節炎市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第8章犬關節炎市場：依最終用戶分類

  • 網路藥房
  • 零售藥房
  • 獸醫醫院和診所

第 9 章依治療類型分類的犬關節炎市場

  • 藥物治療
  • 物理治療
    • 針刺
    • 水療
    • 雷射治療
    • 其他物理治療
  • 手術治療

第10章美洲犬關節炎市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太犬關節炎市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的犬關節炎市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0106

The Canine Arthritis Market was valued at USD 1.81 billion in 2023, expected to reach USD 1.92 billion in 2024, and is projected to grow at a CAGR of 7.88%, to USD 3.08 billion by 2030.

Canine arthritis, a degenerative joint disease, primarily affects the cartilage in dogs, leading to pain, stiffness, and impaired movement. As the prevalence of arthritis in dogs rises, driven by factors such as increasing pet ownership and a growing population of aged dogs, the market for canine arthritis treatment and management is expanding significantly. The necessity for effective arthritis treatments in dogs is undeniable, primarily due to the enhanced understanding of pet welfare and the increasing trend towards humanizing pet healthcare. Applications for arthritis management range from pharmaceutical interventions, such as non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying osteoarthritis drugs (DMOADs), to non-pharmaceutical therapies like physiotherapy, acupuncture, and dietary supplements. The end-use scope involves veterinary clinics, pet hospitals, and even in-home care solutions provided by pet owners who wish to maintain their pets' quality of life. Key growth influencers are advancements in veterinary medicine that provide newer, more effective treatments, and heightened awareness among pet owners about arthritis symptoms and treatment options. Meanwhile, untapped opportunities reside in the development of innovative, minimally invasive treatment techniques and the proliferation of natural or holistic treatment options, aligning with consumer preferences for organic and natural health solutions for their pets. Nonetheless, the market's growth is curtailed by challenges such as high costs associated with advanced treatments, lack of insurance coverage for pets, and insufficient awareness in developing regions. Areas ripe for innovation include enhanced diagnostic tools for early detection and personalized treatment plans based on individual genetic profiles. The nature of the canine arthritis market is dynamic, characterized by rapid advancements in veterinary science and an increasingly informed consumer base, suggesting that businesses should focus not just on treatment efficacy but also on educating consumers and broadening accessibility to drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.81 billion
Estimated Year [2024] USD 1.92 billion
Forecast Year [2030] USD 3.08 billion
CAGR (%) 7.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Arthritis Market

The Canine Arthritis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
    • Innovations in veterinary medicine and treatments for managing canine arthritis effectively
    • Growing awareness and pet owner's willingness to spend on canine health and wellness
    • Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
  • Market Restraints
    • Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
    • Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
  • Market Opportunities
    • Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
    • Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
    • Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
  • Market Challenges
    • High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
    • Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis

Porter's Five Forces: A Strategic Tool for Navigating the Canine Arthritis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Arthritis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Arthritis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Arthritis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Arthritis Market

A detailed market share analysis in the Canine Arthritis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Arthritis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Arthritis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Arthritis Market

A strategic analysis of the Canine Arthritis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Arthritis Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck Animal Health, Nutramax Laboratories, Inc., Vetoquinol S.A., Virbac, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Canine Arthritis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assistive Devices and Joint Support, Disease-Modifying Osteoarthritis Drugs (DMOADs), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Management Drugs, and Surgical Treatments. The Assistive Devices and Joint Support is further studied across Braces, Harnesses, and Other Assistive Devices. The Disease-Modifying Osteoarthritis Drugs (DMOADs) is further studied across Structure-Modifying DMOADs and Symptomatic DMOADs. The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is further studied across Over-the-Counter NSAIDs and Prescription NSAIDs. The Pain Management Drugs is further studied across Opioids, Other Pain Management Drugs, and Steroids. The Surgical Treatments is further studied across Arthroscopic Surgery, Joint Replacement Surgery, and Other Surgical Treatments.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on End User, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Hospitals and Clinics.
  • Based on Therapy Type, market is studied across Drug Therapy, Physical Therapy, and Surgical Therapy. The Physical Therapy is further studied across Acupuncture, Hydrotherapy, Laser Therapy, and Other Physical Therapies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of arthritis among the global canine population due to aging pets and lifestyle
      • 5.1.1.2. Innovations in veterinary medicine and treatments for managing canine arthritis effectively
      • 5.1.1.3. Growing awareness and pet owner's willingness to spend on canine health and wellness
      • 5.1.1.4. Advancements in diagnostic techniques leading to early detection and treatment of arthritis in dogs
    • 5.1.2. Restraints
      • 5.1.2.1. Insufficient number of specialized veterinary professionals to adequately address canine arthritis cases
      • 5.1.2.2. Regulatory challenges affecting the approval and availability of novel treatments for canine arthritis
    • 5.1.3. Opportunities
      • 5.1.3.1. Specialized canine arthritis treatment centers offering holistic and integrative medical approaches
      • 5.1.3.2. Subscription-based delivery of joint supplements and pain relief medications for arthritic dogs
      • 5.1.3.3. Wearable technology for continuous monitoring and management of arthritis symptoms in dogs
    • 5.1.4. Challenges
      • 5.1.4.1. High costs associated with veterinary care and arthritis treatments leading to reduced market accessibility
      • 5.1.4.2. Lack of awareness and education among pet owners about early signs and preventive care for canine arthritis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Canine Arthritis Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assistive Devices and Joint Support
    • 6.2.1. Braces
    • 6.2.2. Harnesses
    • 6.2.3. Other Assistive Devices
  • 6.3. Disease-Modifying Osteoarthritis Drugs (DMOADs)
    • 6.3.1. Structure-Modifying DMOADs
    • 6.3.2. Symptomatic DMOADs
  • 6.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • 6.4.1. Over-the-Counter NSAIDs
    • 6.4.2. Prescription NSAIDs
  • 6.5. Pain Management Drugs
    • 6.5.1. Opioids
    • 6.5.2. Other Pain Management Drugs
    • 6.5.3. Steroids
  • 6.6. Surgical Treatments
    • 6.6.1. Arthroscopic Surgery
    • 6.6.2. Joint Replacement Surgery
    • 6.6.3. Other Surgical Treatments

7. Canine Arthritis Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Canine Arthritis Market, by End User

  • 8.1. Introduction
  • 8.2. Online Pharmacies
  • 8.3. Retail Pharmacies
  • 8.4. Veterinary Hospitals and Clinics

9. Canine Arthritis Market, by Therapy Type

  • 9.1. Introduction
  • 9.2. Drug Therapy
  • 9.3. Physical Therapy
    • 9.3.1. Acupuncture
    • 9.3.2. Hydrotherapy
    • 9.3.3. Laser Therapy
    • 9.3.4. Other Physical Therapies
  • 9.4. Surgical Therapy

10. Americas Canine Arthritis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Canine Arthritis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Canine Arthritis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Incorporated
  • 6. Merck Animal Health
  • 7. Nutramax Laboratories, Inc.
  • 8. Vetoquinol S.A.
  • 9. Virbac
  • 10. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. CANINE ARTHRITIS MARKET RESEARCH PROCESS
  • FIGURE 2. CANINE ARTHRITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANINE ARTHRITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANINE ARTHRITIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BRACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HARNESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER ASSISTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STRUCTURE-MODIFYING DMOADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SYMPTOMATIC DMOADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OVER-THE-COUNTER NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PRESCRIPTION NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PAIN MANAGEMENT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY JOINT REPLACEMENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER SURGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OTHER PHYSICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY CANINE ARTHRITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY CANINE ARTHRITIS MARKET SIZE, BY ASSISTIVE DEVICES AND JOINT SUPPORT, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY CANINE ARTHRITIS MARKET SIZE, BY DISEASE-MODIFYING OSTEOARTHRITIS DRUGS (DMOADS), 2018-2030 (USD MILLION)
  • TABLE 315. ITALY CANINE ARTHRITIS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), 2018-2030 (USD MILLION)
  • TABLE 316. ITALY CANINE ARTHRITIS MARKET SIZE, BY PAIN MANAGEMENT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY CANINE ARTHRITIS MARKET SIZE, BY SURGICAL TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY CANINE ARTHRITIS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)